Endothelial Progenitor Cells Biology in Diabetes Mellitus and Peripheral Arterial Disease and their Therapeutic Potential
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
30413930
DOI
10.1007/s12015-018-9863-4
PII: 10.1007/s12015-018-9863-4
Knihovny.cz E-resources
- Keywords
- Autologous cell therapy, Diabetes mellitus, Endothelial progenitor cells, Peripheral arterial disease, Vascular repair,
- MeSH
- Cell- and Tissue-Based Therapy methods MeSH
- Cell Differentiation * MeSH
- Diabetes Mellitus therapy MeSH
- Endothelial Progenitor Cells cytology MeSH
- Cells, Cultured MeSH
- Humans MeSH
- Peripheral Arterial Disease therapy MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Endothelial progenitors are a population of cells with the inherent capacity to differentiate into mature endothelial cells and proangiogenic paracrine action. These characteristics have led to extensive studies being performed and tested in the treatment of tissue ischemia. The natural course of diabetes mellitus (DM) results in multiple areas of vascular damage. Thus endothelial progenitor cells'(EPCs) beneficial potential is particularly desirable in diabetic patients. In this review, we summarize contemporary knowledge of EPC biology in DM. It has been shown that EPC functions are considerably impaired by DM. The presence of peripheral arterial disease (PAD) seems to further exacerbate the deficiencies of EPCs. However, studies examining EPC counts in PAD and DM observed disparate results, which can be due to a lack of consensus on precise EPC immunotype used in the different studies. Nevertheless, the results of EPC-based autologous cell therapy (ACT) are promising. In addition, EPCs have been shown to bean independent predictor of cardiovascular risk and diabetic foot ulcer healing.
Diabetes Centre Tameside Hospital NHS Foundation Trust and University of Manchester Lancashire UK
Institute for Clinical and Experimental Medicine Prague Czech Republic
See more in PubMed
Lancet. 2002 Aug 10;360(9331):427-35 PubMed
Circulation. 2002 Nov 26;106(22):2781-6 PubMed
Cardiovasc Surg. 2002 Dec;10(6):570-8 PubMed
Trends Cardiovasc Med. 2003 Jul;13(5):201-6 PubMed
J Am Coll Cardiol. 2003 Dec 17;42(12):2073-80 PubMed
Diabetes. 2004 Dec;53(12):3226-32 PubMed
Int J Biochem Cell Biol. 2005 Apr;37(4):715-9 PubMed
Appl Immunohistochem Mol Morphol. 2005 Sep;13(3):205-20 PubMed
Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):257-66 PubMed
Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2140-6 PubMed
Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):113-9 PubMed
Circulation. 2006 Dec 12;114(24):2679-84 PubMed
Am Heart J. 2006 Dec;152(6):1051.e1-8 PubMed
Thromb Haemost. 2007 Dec;98(6):1335-42 PubMed
Circulation. 2009 Feb 10;119(5):699-708 PubMed
Biochem Biophys Res Commun. 2009 Apr 3;381(2):192-7 PubMed
Diabet Med. 2009 Feb;26(2):134-41 PubMed
Int J Cardiol. 2010 Sep 3;143(3):368-72 PubMed
Diabetologia. 2009 Aug;52(8):1464-73 PubMed
Cell Transplant. 2009;18(3):371-80 PubMed
Atherosclerosis. 2010 Mar;209(1):10-7 PubMed
Vasc Med. 2010 Aug;15(4):279-85 PubMed
Endocrine. 2010 Oct;38(2):266-75 PubMed
J Vasc Surg. 2011 Feb;53(2):445-53 PubMed
Circ Cardiovasc Interv. 2011 Feb 1;4(1):26-37 PubMed
Diabetes Obes Metab. 2011 May;13(5):439-45 PubMed
Circ Res. 2012 Feb 17;110(4):624-37 PubMed
Exp Diabetes Res. 2012;2012:921685 PubMed
Cardiovasc Diabetol. 2012 Apr 30;11:46 PubMed
Diabetologia. 2012 Sep;55(9):2501-12 PubMed
Cytometry A. 2012 Oct;81(10):856-64 PubMed
Circ Res. 2013 Feb 1;112(3):510-22 PubMed
Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):555-64 PubMed
Diabetes Metab Res Rev. 2013 Jul;29(5):369-76 PubMed
Circ Res. 2013 Apr 26;112(9):1288-302 PubMed
Clin Cancer Res. 2013 Jul 1;19(13):3360-8 PubMed
Clin Chim Acta. 2014 Jan 1;427:6-10 PubMed
Diabetologia. 2014 Jan;57(1):4-15 PubMed
Diabetes. 2014 Apr;63(4):1353-65 PubMed
Vasc Med. 2013 Dec;18(6):331-9 PubMed
Int J Vasc Med. 2014;2014:589412 PubMed
Front Endocrinol (Lausanne). 2014 Apr 09;5:44 PubMed
Am J Physiol Heart Circ Physiol. 2014 Sep 15;307(6):H869-79 PubMed
J Diabetes Complications. 2015 Jul;29(5):686-90 PubMed
Vasc Med. 2016 Feb;21(1):3-11 PubMed
Cytotherapy. 2016 Feb;18(2):253-62 PubMed
Clin Chim Acta. 2016 Apr 1;455:1-6 PubMed
Mech Ageing Dev. 2016 Oct;159:49-62 PubMed
Tissue Eng Part B Rev. 2016 Oct;22(5):371-382 PubMed
Stem Cells Int. 2016;2016:1803989 PubMed
Int J Cardiol. 2017 Jan 15;227:833-839 PubMed
Diabetes Res Clin Pract. 2017 Feb;124:84-92 PubMed
World J Cardiol. 2017 Jan 26;9(1):1-13 PubMed
Diabetes Res Clin Pract. 2017 Apr;126:263-271 PubMed
Stem Cells Transl Med. 2017 May;6(5):1316-1320 PubMed
Stem Cell Rev. 2018 Feb;14(1):82-91 PubMed
Cell Stem Cell. 2018 Aug 2;23(2):210-225.e6 PubMed
J Exp Med. 2018 Oct 1;215(10):2497-2508 PubMed
Science. 1997 Feb 14;275(5302):964-7 PubMed
Cell Therapy of Severe Ischemia in People with Diabetic Foot Ulcers-Do We Have Enough Evidence?
